View - ResearchSpace@Auckland - The University of Auckland

Donaldson, S. H., W. D. Bennett, et al. (2006). "Mucus clearance and lung function in cystic
fibrosis with hypertonic saline." New England Journal of Medicine 354(3): 24L-50.
Dormans, J. A. M. A., L. van Bree, et al. (1999). "Interspecies differences in time course of
pulmonary toxicity following repeated exposure to ozone." Inhalation Toxicology 11:
309-329.
Dotsch, J., S. Demirakca, et al. (1996). "Airway nitric oxide in asthmatic children and patients
with cystic fibrosis." European Respiratory Journal. Dec:O: 9(12):2537-40.
Doull, I. J., N. J.Freezer, et al. (1995). "Growth of prepubertal children with mild asthma
treated with inhaled beclomethasone dipropionate." American Journal of Respiratory
& Critical Care Medicine 151(6): 17L5-9.
Douma, W. R., H. A. Kerstjens, et al. (2000). "Changes in peak expiratory flow indices as a
proxy for changes in bronchial hypenesponsiveness. Dutch Chronic Non-Specific
Lung Disease study group." European Respiratory Journal 16(2):220-5.
Douma, W. R., H. A. Kerstjens, et al. (1998). "Risk of overtreatment with current peak flow
criteria in self-management plans. Dutch CNSLD Study Group. Chronic Non-Specific
Lung Disease." European Respiratory Journal l2@):848-52.
Douma, W. R., T. W. van der Mark, et al. (1997). "Mini-Wright peak flow meters are reliable
after 5 years use. Dutch CNSLD Study Group." European Respiratory Journal 10(2):
457-9.
Drapier, J. C. and J. B. Hibbs, Jr. (1988). "Differentiation of murine macrophages to express
nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of
mitochondrial iron-sulfur enzymes in the macrophage effector cells." Journal of
Immunology 140(8): 2829 -38.
Drapier, J. C., J. Wietzerbin, et al. (1988). "Interferon-garnma and tumor necrosis factor
induce the L-arginine-dependent cytotoxic effector mechanism in murine
macrophages." European Journal of Immunology 18(10): 1587-92.
Dubois, A. B., J. S. Douglas, et al. (1998). "Production and absorption of nitric oxide gas in
the nose." Journal of Applied Phvsiology M(): l2I7-24.
Duddridge, M., C. Ward, et al. (1993). "Changes in bronchoalveolar lavage inflammatory
cells in asthmatic patients treated with high dose inhaled beclomethasone
dipropionate. " European Respiratory Journal 6(4): 489 -97 .
Dun, N. J., S. L. Dun, et al. (1992). "Nitric oxide synthase immunoreactivity in rat spinal
cord. " Neuroscience Letters 147 (2): 217 -20.
Dun, N. J., S. L. Dun, et al. (1993). "Nitric oxide synthase immunoreactivity in rat superior
cervical ganglia and adrenal glands." Neuroscience Irtters 158(1): 51-a.
Dundas, I. and S. McKenzie (2006). "Spirometry in the diagnosis of asthma in children."
Current Opinion in Pulmonary Medicine 12(l):28-33.
Dunlop, K. A., D. J. Carson, et al. (2004). "Monitoring growth in asthmatic children treated
with high dose inhaled glucocorticoids does not predict adrenal suppression."
Archives of Disease in Childhood 89(8): 713-6.
Dunnill, M. S. (1960). "The pathology of asthma, with special reference to changes in the
bronchial mucosa." Journal of Clinical Pathology 13:27-33.
Dupont, L. J., M. G. Demedts, et al. (2003). "Prospective evaluation of the validity of exhaled
nitric oxide for the diagnosis of asthma." Chest 123(3):751-6.
Dupont, L. J., F. Rochette, et al. (1998). "Exhaled nitric oxide correlates with airway
hyperresponsivenessinsteroid-naivepatientswithmildasthma.''@
Respiratory & Critical Care Medicine 157(3 Pt l): 894-8.
Dusting, G. J. and P. S. Macdonald (1995). "Endogenous nitric oxide in cardiovascular
disease and transplantation." Annals of Medicine 27(3):395-406.
Ebina, M., T. Takahashi, et al. (1993). "Cellular hypertrophy and hyperplasia of airway
smooth muscles underlying bronchial asthma. A 3-D morphometric study." American
Review of Respiratory Disease 148(3): 720-6.